Prexton therapeutics
Integrates molecular, behavioral and chemistry technologies to address Parkinson’s disease and other brain disorders. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€905m (Public information from Mar 2018)
Company register number 67516114
Oss Noord-Brabant (HQ)
Authorizing premium user...